MMED MiniMed Group, Inc. - Common Stock

NASDAQ · · View on SEC EDGAR ↗
$19.95
Price · Aug 19, 2026
Fundamentals as of Jun 29, 2026
52W Range
$11–$21
91% of range
Analyst Rating
BUY
18 analysts
Price Target
$21
+4% upside
P/E (TTM)
-15.3
ROE
-9.3%
Net Profit Margin
-10.7%

MMED Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$19.95
Market Cap
$5.60B
P/E (TTM)
-15.3
EPS (TTM)
$-1.30
Revenue (TTM)
$3.10B
Div Yield
—
ROE
-9.3%
Debt/Equity
—
52W Range
$11 – $21

MMED Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $3.10B
3-point trend, +25.6%
2024-04-26 → 2026-04-24
EPS $-1.30
3-point trend, -195.5%
2024-04-26 → 2026-04-24
Free Cash Flow $-420M
2026-04-24 → 2026-04-24
Margins -10.7%
2026-04-24 → 2026-04-24

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
MMED
Peer Median
P/E (TTM)
-15.3
34.5
P/S (TTM)
1.8
3.0
P/B
1.6
3.0
Price / FCF
-13.3
—

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
MMED
Peer Median
Gross Margin
54.2%
49.2%
Operating Margin
-6.1%
—
Net Profit Margin
-10.7%
4.7%
ROA
-7.5%
2.6%
ROE
-9.3%
5.6%
ROIC
-8.8%
—

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
MMED
Peer Median
Current Ratio
1.9
2.9
Quick Ratio
0.7
—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
MMED
Peer Median
Revenue YoY
3-point trend, +25.6%
14.2%
—

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
MMED
Peer Median
EPS (Diluted)
3-point trend, -195.5%
$-1.30
—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
MMED
Peer Median

MMED Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 18 analysts
  • Strong Buy 6 33.3%
  • Buy 10 55.6%
  • Hold 2 11.1%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

12 analysts · 2026-08-19
Median target $20.50 +2.8%
Mean target $20.83 +4.5%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.57%
Next Report
Sep 01, 2026
Period EPS Actual EPS Est Surprise
Dec. 31, 2026 $-0.68 $-0.17 —
June 30, 2026 $-0.68 $-0.17 -0.51%
March 31, 2026 $-0.47 $0.16 -0.63%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
MMED $3.71B -10.2 14.2% -10.7% -9.3% 54.2%
MDLN — -4200.0 11.5% 4.1% 21.6% 26.4%
COO $13.70B 37.4 5.1% 9.2% 4.6% 65.5%
SOLV $13.75B 8.9 0.86% 18.7% 35.8% 53.5%
ALGN $11.14B 27.6 0.90% 10.2% 10.3% 67.2%
LNTH $4.30B 19.5 0.50% 15.2% 20.7% 61.1%
MMSI $5.24B 41.4 11.8% 8.5% 8.4% 48.7%
HAE $2.45B 26.4 -2.0% 7.3% 11.8% 59.0%
ICUI $3.52B 4755.7 -6.3% 0.03% 0.03% 36.8%
QDEL $1.99B -1.8 -1.9% -41.4% -48.0% —
XRAY $2.28B -3.8 -3.0% -16.2% -36.4% 50.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 14
Annual Income Statement data for MMED
Metric Trend 20262025
Revenue 2-point trend, +14.3% $3.10B $2.71B
Cost of Revenue 2-point trend, +19.8% $1.42B $1.19B
Gross Profit 2-point trend, +9.9% $1.68B $1.53B
SG&A Expense 2-point trend, +9.5% $1.18B $1.08B
Operating Income 2-point trend, -30.1% $-190M $-146M
Other Non-op 2-point trend, +200.0% $1M $-1M
Pretax Income 2-point trend, -28.6% $-189M $-147M
Income Tax 2-point trend, +146.2% $128M $52M
Net Income 2-point trend, -56.3% $-333M $-213M
EPS (Basic) 2-point trend, -54.8% $-1.30 $-0.84
EPS (Diluted) 2-point trend, -54.8% $-1.30 $-0.84
Shares (Basic) 2-point trend, +1.5% 256,600,000 252,800,000
Shares (Diluted) 2-point trend, +1.5% 256,600,000 252,800,000
EBITDA $-34M ·
Balance Sheet 24
Annual Balance Sheet data for MMED
Metric Trend 20262025
Cash & Equivalents 2-point trend, +2609.1% $298M $11M
Receivables 2-point trend, -64.9% $200M $570M
Inventory 2-point trend, +9.6% $341M $311M
Other Current Assets 2-point trend, +12.5% $54M $48M
Current Assets 2-point trend, +43.6% $1.35B $939M
PP&E (Net) 2-point trend, +0.7% $711M $706M
PP&E (Gross) 2-point trend, +9.0% $1.49B $1.37B
Accum. Depreciation 2-point trend, +17.8% $781M $663M
Goodwill 2-point trend, +0.0% $2.26B $2.25B
Intangibles 2-point trend, -18.9% $107M $132M
Other Non-current Assets 2-point trend, -2.0% $147M $150M
Total Assets 2-point trend, +10.2% $4.63B $4.20B
Accounts Payable 2-point trend, -20.5% $163M $205M
Current Liabilities 2-point trend, -1.1% $702M $710M
Capital Leases 2-point trend, -19.6% $45M $56M
Other Non-current Liabilities 2-point trend, +95.7% $317M $162M
Total Liabilities 2-point trend, +17.0% $1.02B $871M
Common Stock 2-point trend, +3000000.00 $3M $0
Paid-in Capital 2-point trend, +3736000000.00 $3.74B $0
Retained Earnings 2-point trend, -116000000.00 $-116M $0
AOCI 2-point trend, -500.0% $-12M $3M
Stockholders' Equity 2-point trend, +8.4% $3.61B $3.33B
Liabilities + Equity 2-point trend, +10.2% $4.63B $4.20B
Shares Outstanding 2-point trend, +280819988.00 280,819,988 0
Cash Flow 12
Annual Cash Flow data for MMED
Metric Trend 20262025
D&A 2-point trend, +9.1% $156M $143M
Stock-based Comp 2-point trend, +12.2% $46M $41M
Deferred Tax 2-point trend, -2400.0% $-50M $-2M
Amort. of Intangibles 2-point trend, -10.3% $26M $29M
Other Non-cash $-16M ·
Operating Cash Flow 2-point trend, -240.7% $-197M $140M
CapEx 2-point trend, +15.5% $223M $193M
Investing Cash Flow 2-point trend, -20.7% $-233M $-193M
Financing Cash Flow 2-point trend, +7060.0% $716M $10M
Net Change in Cash 2-point trend, +767.4% $287M $-43M
Taxes Paid 2-point trend, +2000000.00 $2M $0
Free Cash Flow $-420M ·
Profitability 8
Annual Profitability data for MMED
Metric Trend 20262025
Gross Margin 54.2% ·
Operating Margin -6.1% ·
Net Margin -10.7% ·
Pretax Margin -6.1% ·
EBITDA Margin -1.1% ·
ROA -7.5% ·
ROE -9.3% ·
ROIC -8.8% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for MMED
Metric Trend 20262025
Current Ratio 1.9 ·
Quick Ratio 0.7 ·
Efficiency 3
Annual Efficiency data for MMED
Metric Trend 20262025
Asset Turnover 0.7 ·
Inventory Turnover 4.4 ·
Receivables Turnover 8.1 ·
Per Share 5
Annual Per Share data for MMED
Metric Trend 20262025
Book Value / Share $12.86 ·
Revenue / Share $12.09 ·
Cash Flow / Share $-0.77 ·
Cash / Share $1.06 ·
EPS (TTM) $-1.30 ·
Growth Rates 1
Annual Growth Rates data for MMED
Metric Trend 20262025
Revenue YoY 2-point trend, +43.1% 14.2% 10.0%
Valuation (TTM) 10
Annual Valuation (TTM) data for MMED
Metric Trend 20262025
Revenue TTM $3.10B ·
Net Income TTM $-333M ·
Market Cap $3.71B ·
P/E -10.2 ·
P/S 1.2 ·
P/B 1.0 ·
P / Tangible Book 3.0 ·
P / Cash Flow -18.8 ·
P / FCF -8.8 ·
Earnings Yield -9.8% ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2026-04-242025-04-252024-04-26
Revenue $3.10B$2.71B$2.47B
Gross Margin % 54.2%——
Operating Margin % -6.1%——
Net Income $-333M$-213M$-112M
Diluted EPS $-1.30$-0.84$-0.44
Balance Sheet
2026-04-242025-04-252024-04-26
Current Ratio 1.9——
Quick Ratio 0.7——
Cash Flow
2026-04-242025-04-252024-04-26
Free Cash Flow $-420M——

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Company insiders 6 insiders · 3 officers · 0 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Chad Spooner EVP, Chief Financial Officer July 28, 2026 F 362,707 0 0 $0
Gillian Chandrasena SVP, Chief HR Officer July 28, 2026 F 172,745 0 0 $0
John Gyurci VP, Chief Accounting Officer July 1, 2026 A 39,941 0 0 $0
Ali Dianaty — July 31, 2026 F 315,158 0 0 $0
Courtney Nelson Wills — July 31, 2026 F 136,384 0 0 $0
Que Dallara — July 31, 2026 F 884,749 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 7 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWN · iShares Trust 0.03% 265,996 SH Aug. 8, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.03% 25,024 SH Aug. 8, 2026 Daily
OMFS · Invesco Exchange-Traded Self-Indexe… 0.03% 3,717 SH Aug. 8, 2026 Daily
IWM · iShares Trust 0.02% 737,097 SH Aug. 8, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 165,581 SH Aug. 8, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 323,325 SH Aug. 8, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 2,442 SH Aug. 8, 2026 Daily